DAVID RANDALL GROSSHANS to Proton Therapy
This is a "connection" page, showing publications DAVID RANDALL GROSSHANS has written about Proton Therapy.
Connection Strength
9.046
-
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons. Neuro Oncol. 2021 02 25; 23(2):284-294.
Score: 0.358
-
A DNA damage multiscale model for NTCP in proton and hadron therapy. Med Phys. 2020 Apr; 47(4):2005-2012.
Score: 0.333
-
Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019 06 10; 21(6):809-818.
Score: 0.318
-
Chemotherapy Plus Proton or Photon Radiation on a Trial. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):518-519.
Score: 0.297
-
Radiobiological issues in proton therapy. Acta Oncol. 2017 Nov; 56(11):1367-1373.
Score: 0.280
-
The role of image-guided intensity modulated proton therapy in glioma. Neuro Oncol. 2017 04 01; 19(suppl_2):ii30-ii37.
Score: 0.273
-
Proton therapy - Present and future. Adv Drug Deliv Rev. 2017 01 15; 109:26-44.
Score: 0.267
-
Spot scanning proton therapy minimizes neutron dose in the setting of radiation therapy administered during pregnancy. J Appl Clin Med Phys. 2016 09 08; 17(5):366-376.
Score: 0.262
-
Proton therapy for paediatric medulloblastoma. Lancet Oncol. 2016 Mar; 17(3):258-259.
Score: 0.252
-
Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):540-6.
Score: 0.229
-
A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol. 2014 Sep 11; 9:202.
Score: 0.229
-
Intensity modulated proton therapy for craniospinal irradiation: organ-at-risk exposure and a low-gradient junctioning technique. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):637-44.
Score: 0.228
-
Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):354-61.
Score: 0.226
-
In-beam PET imaging for on-line adaptive proton therapy: an initial phantom study. Phys Med Biol. 2014 Jul 07; 59(13):3373-88.
Score: 0.224
-
Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):384-91.
Score: 0.218
-
Comparison of proton therapy techniques for treatment of the whole brain as a component of craniospinal radiation. Radiat Oncol. 2013 Dec 17; 8:289.
Score: 0.217
-
Pilocytic astrocytoma with leptomeningeal dissemination. Childs Nerv Syst. 2013 Mar; 29(3):441-50.
Score: 0.202
-
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
Score: 0.115
-
Investigation of intra-fractionated range guided adaptive proton therapy (RGAPT): II. Range-shift compensated on-line treatment adaptation and verification. Phys Med Biol. 2024 Jul 17; 69(15).
Score: 0.113
-
Investigation of intra-fractionated range guided adaptive proton therapy: I. On-line PET imaging and range measurement. Phys Med Biol. 2024 Jul 17; 69(15).
Score: 0.113
-
Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiother Oncol. 2024 06; 195:110270.
Score: 0.111
-
Proton Therapy Mediates Dose Reductions to Brain Structures Associated With Cognition in Children With Medulloblastoma. Int J Radiat Oncol Biol Phys. 2024 May 01; 119(1):200-207.
Score: 0.108
-
Incorporating variable RBE in IMPT optimization for ependymoma. J Appl Clin Med Phys. 2024 Jan; 25(1):e14207.
Score: 0.108
-
Intensity modulated proton arc therapy via geometry-based energy selection for ependymoma. J Appl Clin Med Phys. 2023 Jul; 24(7):e13954.
Score: 0.103
-
Superior verbal learning and memory in pediatric brain tumor survivors treated with proton versus photon radiotherapy. Neuropsychology. 2023 Feb; 37(2):204-217.
Score: 0.101
-
Renal function in abdominal neuroblastoma patients undergoing proton radiotherapy. Pediatr Blood Cancer. 2023 01; 70(1):e29981.
Score: 0.100
-
Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. 2022 09 01; 24(9):1571-1581.
Score: 0.099
-
Roadmap: helium ion therapy. Phys Med Biol. 2022 08 05; 67(15).
Score: 0.099
-
Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy. Pediatr Blood Cancer. 2022 06; 69(6):e29645.
Score: 0.096
-
Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Cancer. 2021 Oct 15; 127(20):3865-3871.
Score: 0.092
-
Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy. Pediatr Blood Cancer. 2021 09; 68(9):e29125.
Score: 0.091
-
A framework for voxel-based assessment of biological effect after proton radiotherapy in pediatric brain cancer patients using multi-modal imaging. Med Phys. 2021 Jul; 48(7):4110-4121.
Score: 0.091
-
Treatment age and neurocognitive outcomes following proton beam radiotherapy for pediatric low- and intermediate-grade gliomas. Pediatr Blood Cancer. 2021 08; 68(8):e29096.
Score: 0.091
-
Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1496-1504.
Score: 0.090
-
Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):718-725.
Score: 0.089
-
Roadmap: proton therapy physics and biology. Phys Med Biol. 2021 02 26; 66(5).
Score: 0.089
-
A biological effect-guided optimization approach using beam distal-edge avoidance for intensity-modulated proton therapy. Med Phys. 2020 Sep; 47(9):3816-3825.
Score: 0.086
-
Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns. Sci Rep. 2020 02 21; 10(1):3199.
Score: 0.083
-
Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
Score: 0.082
-
Systematic microdosimetric data for protons of therapeutic energies calculated with Geant4-DNA. Phys Med Biol. 2019 11 04; 64(21):215018.
Score: 0.082
-
Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27952.
Score: 0.080
-
Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro Oncol. 2019 05 06; 21(5):686-695.
Score: 0.079
-
Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma. Pediatr Blood Cancer. 2019 08; 66(8):e27786.
Score: 0.079
-
Reply to Comment on 'Linear energy transfer incorporated intensity modulated proton therapy optimization'. Phys Med Biol. 2019 02 27; 64(5):058002.
Score: 0.078
-
Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019 Mar; 46(3):e53-e78.
Score: 0.078
-
Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Radiother Oncol. 2019 05; 134:143-150.
Score: 0.078
-
Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):316-324.
Score: 0.078
-
Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy. Phys Med Biol. 2019 01 08; 64(2):025004.
Score: 0.077
-
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care. Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):724-733.
Score: 0.077
-
Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
Score: 0.075
-
Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival. Oper Neurosurg (Hagerstown). 2018 08 01; 15(2):131-143.
Score: 0.075
-
Toward A variable RBE for proton beam therapy. Radiother Oncol. 2018 07; 128(1):68-75.
Score: 0.074
-
National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):152-168.
Score: 0.074
-
Comparison of Monte Carlo and analytical dose computations for intensity modulated proton therapy. Phys Med Biol. 2018 02 09; 63(4):045003.
Score: 0.072
-
Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):169-176.
Score: 0.072
-
Proceedings of the National Cancer Institute Workshop on Charged Particle Radiobiology. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):816-831.
Score: 0.072
-
Linear energy transfer incorporated intensity modulated proton therapy optimization. Phys Med Biol. 2017 12 19; 63(1):015013.
Score: 0.072
-
A new formalism for modelling parameters a and ? of the linear-quadratic model of cell survival for hadron therapy. Phys Med Biol. 2017 Oct 03; 62(20):8041-8059.
Score: 0.071
-
A model for relative biological effectiveness of therapeutic proton beams based on a global fit of cell survival data. Sci Rep. 2017 08 21; 7(1):8340.
Score: 0.070
-
Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol. 2017 07; 124(1):89-97.
Score: 0.069
-
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016 12; 121(3):395-401.
Score: 0.066
-
A multi-institutional pilot survey of anesthesia practices during proton radiation therapy. Pract Radiat Oncol. 2016 May-Jun; 6(3):155-159.
Score: 0.062
-
Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code. Med Phys. 2015 Nov; 42(11):6234-47.
Score: 0.062
-
A Retrospective Evaluation of the Benefit of Referring Pediatric Cancer Patients to an External Proton Therapy Center. Pediatr Blood Cancer. 2016 Feb; 63(2):262-9.
Score: 0.061
-
Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics. Radiother Oncol. 2015 Aug; 116(2):309-15.
Score: 0.061
-
Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy. Spine (Phila Pa 1976). 2015 Apr 15; 40(8):544-9.
Score: 0.060
-
Embryonal brain tumors. Cancer J. 2014 Nov-Dec; 20(6):397-402.
Score: 0.058
-
Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20; 32(33):3762-70.
Score: 0.058
-
A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol. 2014 Oct; 113(1):77-83.
Score: 0.058
-
Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1143-52.
Score: 0.057
-
Non-invasive anesthesia for children undergoing proton radiation therapy. Radiother Oncol. 2014 Apr; 111(1):30-4.
Score: 0.055
-
Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):277-84.
Score: 0.051
-
Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemia. BMJ Case Rep. 2012 Jul 11; 2012.
Score: 0.049
-
Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1419-24.
Score: 0.048
-
Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):643-52.
Score: 0.044
-
Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. J Clin Oncol. 2020 02 10; 38(5):454-461.
Score: 0.020
-
Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy. Radiother Oncol. 2018 07; 128(1):128-132.
Score: 0.018
-
Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol. 2016 Apr 01; 34(10):1043-9.
Score: 0.016